What is Haemonetics's debt repayments?

Haemonetics (HAE) reported debt repayments of -$4.69M in Q1 2026.

How has Haemonetics's debt repayments changed year-over-year?

Haemonetics's debt repayments decreased by 399.9% year-over-year, from $1.56M to -$4.69M.

What is the long-term trend for Haemonetics's debt repayments?

Over 4 years (2022 to 2026), Haemonetics's debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $17.5M to $0.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Haemonetics HAE Debt Repayments

Debt Repayments at other companies

AbbottABT

$1.42B+41.5%

TFX

TeleflexTFX

$25.25M-48.6%

MedtronicMDT

$1.77B—

LivaNovaLIVN

$95.94M+2,093%

ICU MedicalICUI

$4.69M-90.2%

DanaherDHR

$1.43B—

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's debt repayments?: Haemonetics (HAE) reported debt repayments of -$4.69M in Q1 2026.
How has Haemonetics's debt repayments changed year-over-year?: Haemonetics's debt repayments decreased by 399.9% year-over-year, from $1.56M to -$4.69M.
What is the long-term trend for Haemonetics's debt repayments?: Over 4 years (2022 to 2026), Haemonetics's debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $17.5M to $0.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.